Multiple attempts have been made to obtain clarification on the initial reporter facility name.However, no further information has been made available.Initial reporter phone: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
During a clinical trial, sponsored by biosense webster, inc.On (b)(6) 2020 it was reported that a (b)(6) year-old male patient (61kg, 155cm) underwent a paroxysmal atrial fibrillation (afib) ablation procedure using an unknown thermocool® smart touch® sf.The patient suffered paralytic gastric dilatation.The procedure was a success.On (b)(6) 2020 a paralytic gastric dilatation occurred and on (b)(6) 2020 recovery from paralytic gastric dilatation was reported.Per the study investigator it was serious, relationship with the device was not related and relationship with the procedure was related.Additional information: this adverse event was discovered post use of biosense webster products.The physician¿s opinion on the cause of this adverse event was procedure related.Patient was reported as fully recovered.A thermocool® smarttouch® sf catheter was used.
|